aim investigate oprm1 118ag polymorphism affects analgesic respiratory depressive effects alfentanil assess role therapeutic range alfentanil methods singleoccasion design NUMBER heterozygous homozygous carriers variant oprm1 118g allele received computerized infusion alfentanil achieve target concentrations NUMBER NUMBER NUMBER NUMBER concentration level analgesia assessed means electrically chemically induced pain respiratory depression quantified hypercapnic challenge breathing frequency results relationship percent change tolerance electrical stimuli measured alfentanil concentrations described power models flatter carriers 118g variant allele indicating decreased opioid analgesia p005 chemically induced pain flatter analgesia versus concentration relationship homozygous carriers 118g allele p005 relationship percent changes respiratory parameters significantly flatter p001 homozygous carriers compared heterozygous carriers 118g allele higher alfentanil concentrations needed homozygous carriers compared subjects times produce degree analgesia times higher alfentanil concentrations needed produce degree respiratory depression conclusion oprm1 118ag polymorphism affects analgesic respiratory depressive effects alfentanil analgesic effects partly decreased heterozygous carriers depending pain model respiratory depressive effects decreased homozygous carriers variant 118g allele therapeutic range alfentanil broadened homozygous carriers open label non carriers effect site non carriers non carriers wild type NUMBER NUMBER NUMBER NUMBER ng ml